Business Wire

ARCTIC-BLUE-BEVERAGES

8.9.2021 12:20:05 CEST | Business Wire | Press release

Share
Award-winning Arctic Blue Beverages Yet Again Claim Prizes at the “World Championships” of the Beverage Industry

Arctic Blue Beverages was awarded for its Arctic Blue Legacy Gin, which received the Gold Medal in the “Cast Finish” category, and its Arctic Blue Oat Liqueur, which received the Bronze Medal in the “Cream / Cream alternative based” category.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210908005581/en/

“It’s nice to see how our quality products are gaining more and more international recognition. We get inspiration and ingredients for our products from the pure Finnish nature, and it’s great that they are also valued elsewhere in the world,” says Valtteri Eroma , CEO of Arctic Blue Beverages Oy.

Arctic Blue Legacy Gin, which was awarded Gold and 95 points, was described by the jury as “exceptional” and praised as a “well-balanced, characterful gin with gentle juniper and toasted wood aromas.” Arctic Blue Legacy Gin is a premium product that is matured in oak barrels and will be launched on the market next year.

“Arctic Blue Legacy Gin will be a very special product for us also in terms of packaging. The design work is still in progress, so we cannot reveal what the final product will look like, but I can promise that it will be something unique,” says Eroma.

Bronze was awarded in the competition to the world’s first gin-based oat liqueur, Arctic Blue Oat, what was launched in Finland in summer 2021. It has been received well in Finland and also impressed the IWSC jury, which described it as “aromatic and herbal with a creamy mouthfeel and undertones of chocolate, cinnamon and vanilla spice.” Arctic Blue Oat is available in Finland from Alko outlets.

Awards for Arctic Blue Beverages:

Arctic Blue Legacy Gin: GOLD (95pts) (Cask Finish)

Arctic Blue Oat Liqueur: BRONZE (Cream / Cream alternative based)

Arctic Blue Beverages Oy is a Finnish beverage company whose best-known product is Arctic Blue Gin, which has been awarded as the best gin in the world. Arctic Blue Gin has the sophisticated taste of blueberry, juniper, spicy and coniferous artisan gin based on domestic berries, fresh spring water and Nordic plants. Arctic Blue Gin is exported to Japan and more than twenty other countries all over the world. The global availability of the company’s products and its product range are being further expanded in 2021.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

1NCE and Pessl Instruments Connect Smart Farms Worldwide29.7.2026 10:00:00 CEST | Press release

IoT specialists 1NCE and Pessl Instruments help farmers in 80 countries to connect and manage thousands of weather stations Smart farming solution improves water and fertilizer efficiency Both companies provide critical components at a 99.97% service availability 1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, and Pessl Instruments, a global leader in smart agriculture, announce today the roll-out of the METOS by Pessl Instruments weather network solution powered by 1NCE. The smart farming solution provided by Pessl Instruments connects thousands of weather stations and field sensors through a single platform, providing farmers real-time data of precipitation and soil moisture, extreme weather forecasting and crop disease risk in more than 80 countries. The main challenge for the deployment of smart farming solutions is always providing good coverage in rural areas. Thanks to 1NCE’s global connectivity service available in more

Cognita Reply Named an OpenAI Advanced Partner to Accelerate Enterprise Adoption of Frontier AI29.7.2026 10:00:00 CEST | Press release

Cognita Reply, the Reply Group company specialising in OpenAI technologies, today announced that it has been named an OpenAI Advanced Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729234340/en/ Cognita Reply, the Reply Group company specialising in OpenAI technologies, today announced that it has been named an OpenAI Advanced Partner within the OpenAI Partner Network, to accelerate enterprise adoption of frontier AI The OpenAI Partner Network is a global programme for partners to build, sell and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities and customer relationships, while equipping them with resources, enablement and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. We’re pleased to welcome Cognita Reply as an OpenAI Advanced Partner. The Cognita Reply

T964 Named as Uptime Institute Business Partner to Power Iraq’s Digital Infrastructure29.7.2026 09:02:00 CEST | Press release

Agreement signed at U.S.-Iraq Business Summit brings the world’s most trusted digital infrastructure standards to Iraq Uptime Institute and Tech964 Holding Limited (T964), Iraq’s leading digital infrastructure company, today announced a landmark strategic partnership to accelerate Iraq’s digital transformation. The partnership combines the world’s leading authority in digital infrastructure standards with the company building the critical infrastructure underpinning Iraq’s digital economy. The agreement was signed at the U.S. Chamber of Commerce U.S.-Iraq Business Summit on July 17, 2026, during the official U.S. visit of Iraqi Prime Minister Ali Al-Zaidi, at a historic summit that produced more than 50 agreements valued at over USD $60 billion and marked a powerful new era of economic cooperation between the United States and Iraq. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260728066813/en/ T964 named as Uptime Institut

ELFA Vape Aerosols Less Harmful Than Cigarette Smoke: Study29.7.2026 09:00:00 CEST | Press release

Levels of 17 analytes usually found in cigarette smoke tested in aerosols from ELFBAR ELFA pods 10 harmful constituents below detectable levels, with formaldehyde and acetaldehyde up to 99.9%* lower than those in cigarette smoke Metals detected well below safety thresholds Complete switching to ELFA significantly reduces or brings to zero adult users’ exposure to harmful constituents Levels of 17 constituents in aerosols from ELFA, a pod system vape by ELFBAR, are undetected or substantially lower than those in cigarette smoke, reveals the latest peer-reviewed study published by iScience, a scientific journal. Aerosols in this study are generated by facilities under standardized laboratory conditions. The tests involve 17 cigarette smoke-related analytes during vaporization of vape liquid from ELFA’s pods in four flavors, including Super Tobacco, Spearmint, Strawberry Ice and Watermelon. Findings indicate that adult smokers completely transitioning to ELFA pod system could reduce, or e

PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants29.7.2026 09:00:00 CEST | Press release

François Romaneix is appointed Chairman of the Board of Directors.Prof. Philippe Leboulch joins the Board of Directors and the Scientific Advisory Board.Prof. Alain Fischer becomes Chairman of the Scientific Advisory Board.Isabelle Buckle and Tom Tice are appointed to the Board of Directors. PK MED, a French biotechnology company founded by Truffle Capital (founder of Abivax and Carvolix), developing therapeutic micro-implants to address major medical needs, today announces a significant strengthening of its governance. The company is strengthening the structure of its Board of Directors and Scientific Advisory Board to support the upcoming Phase 2 entry of its most advanced drug candidate, ARTHRELIS (treatment of gout flares), and to accelerate the preclinical development of ENGRAFTIS (treatment of poor graft function following bone marrow transplantation). The Board of Directors of PK MED welcomes four key new members: François Romaneix, appointed Chairman of the Board of Directors.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye